XML 42 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (Parenthetical)
 12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
Payment of management fee | $ $ 463,223
Fair value of warrants issued as consideration for placement agent services | $ $ 249,612
Expected term of options (years) 5 years
Share price $ 0.258 [1]
Minimum [Member]  
Exercise price 0.258
Fair value 0.004
Maximum [Member]  
Exercise price 5.400
Fair value $ 0.130
Dividend Yield [Member]  
Fair value of warrant measurement inputs 0
Expected Volatility [Member]  
Fair value of warrant measurement inputs 56.21 [2]
Risk Free Interest Rate [Member]  
Fair value of warrant measurement inputs 2.5
Seven Board Members and Three Members of the Senior Management Team [Member]  
Issuance of shares of common stock | $ $ 1,705,261
[1] The Common Stock price, per share reflects the Company's management's estimation of the fair value per share of Common Stock as of June 2019. In reaching its estimation for such periods, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series D Units at December 31, 2018.
[2] Due to the low trading volume of the Company's Common Stock, the expected volatility was based on a sample of 248 companies operating in the Healthcare Products industry.